Passionate about IP! Since June 2003 the IPKat has covered copyright, patent, trade mark, designs, info-tech and confidentiality issues from a mainly UK and European perspective. Read, post comments and participate!

The team is Eleonora Rosati, Annsley Merelle Ward and Merpel. E-mail the Kats here!

The team is joined by GuestKats Söğüt Atilla, Oliver Fairhurst, Claire Gregg, Georgia Jenkins and Marcel Pemsel.

SpecialKats: Verónica Rodríguez Arguijo (TechieKat), Rose Hughes (PatKat) and Jocelyn Bosse (Book Review Editor).

InternKats: Wissam Bentazar, Simone Lorenzi and Kliment Markov.
Results for amgen v sanofi
UPC takes strong stance on therapeutic antibody inventions (Sanofi v Amgen, UPC_CFI_1/2023) UPC takes strong stance on therapeutic antibody inventions (Sanofi v Amgen, UPC_CFI_1/2023) Reviewed by Dr Rose Hughes on Thursday, July 18, 2024 Rating: 5
First patent revocation actions before the UPC have been filed First patent revocation actions before the UPC have been filed Reviewed by Benjamin Goh on Monday, June 26, 2023 Rating: 5
US Supreme Court decision in Amgen v Sanofi: The European Perspective US Supreme Court decision in Amgen v Sanofi: The European Perspective Reviewed by Dr Rose Hughes on Wednesday, May 31, 2023 Rating: 5
Fordham 27 (Report 9): Biologics and Biosimilars Fordham 27 (Report 9): Biologics and Biosimilars Reviewed by Annsley Merelle Ward on Sunday, April 28, 2019 Rating: 5
Subscribe to: Posts ( Atom )
Powered by Blogger.